Dermatology
Latest News
Isotretinoin users do not have higher suicide risk: meta-analysis
The analysis showed that the 1-year absolute risk from between two and eight studies of suicide attempts, suicidal ideation, completed suicides,...
News
FDA warns of potentially lethal reaction to seizure meds
Diagnosis is often difficult because early signs and symptoms, such as fever and swollen lymph nodes, may be present without evidence of a rash....
Latest News
New consensus guide on rare drug hypersensitivity reaction
To support clinicians in diagnosing and managing DRESS, a steering committee conducted a literature review to examine current research, identify...
Latest News
Laser epilation may reduce pilonidal disease recurrences when added to standard care
The study is “the first, to our knowledge, to compare LE as an adjunct to standard care versus standard care alone and demonstrate a decrease in...
Latest News
Tapinarof effective for AD in patients as young as 2 years
Tapinarof cream, 1%, an aryl hydrocarbon receptor agonist, was approved in 2022 for treating plaque psoriasis in adults.
Latest News
Parent concerns a factor when treating eczema in children with darker skin types
For the parent, the pigmentation changes, rather than the inflammation, might be the governing issue and the reason that he or she brought the...
Latest News
Lebrikizumab gets European nod for treating moderate-to-severe atopic dermatitis
Lebrikizumab remains under review in the United States.
Latest News
AAD updates guidelines for managing AD with phototherapy and systemic therapies
The work group recommended the inclusion of active comparator arms in randomized, controlled trials as new systemic therapies continue to be...
Latest News
Review estimates acne risk with JAK inhibitor therapy
Acne has been reported to be an adverse effect of JAK inhibitors, but not much is known about how common acne is overall.
From the Journals
Dupilumab-associated lymphoid reactions require caution
In cases involving unexpected responses or atypical presentations, clinicians must have a low threshold for stopping dupilumab.
Latest News
Birch bark–derived treatment reduces daily dressings in patients with epidermolysis bullosa
Despite being approved in Europe, Oleogel-S10 has not yet been approved to treat EB in the United States.